MEDCO HEALTH SOLUTIONS INC (MHS) Peer Comparison
$15,630.68
$-68.29
(-0.44%)
As on 17-Sep-2024 09:30EDT
Market cap
$-- Mln
Revenue (TTM)
$69,076 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 9,571 | 1,105 | 892 | 839 |
Revenue ($ Mln) |
69,076 | 5,371 | 73 | 208 | 1,653 |
Net Profit ($ Mln) |
1,367.70 | -169.00 | 36.72 | 52.16 | 48.98 |
Net Margin (%) |
1.98 | -3.15 | 50.13 | 25.13 | 2.96 |
RoE (%) |
34.23 | -1.85 | 11.69 | 30.61 | 3.61 |
Price to Earnings |
-- | -- | 28.19 | 17.55 | 11.87 |
Price-To-Book |
-- | 1.11 | 2.85 | 4.41 | 0.58 |
Income Statement ($ Mln)
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
70,063.30 | 1,622.45 | -- | -- | 2,864.50 |
|
Cost of Revenue
|
65,397.90 | -- | -- | -- | 821.00 |
|
Gross Profit
|
4,665.40 | 1,622.45 | -- | -- | 2,043.50 |
|
Operating Expenses
|
-- | 400.32 | -- | -- | 2,970.10 |
|
Operating Profit (EBIT)
|
2,635.20 | 438.44 | -- | -- | -379.70 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
2,375.80 | 438.44 | -- | -- | -242.40 |
|
Provision for Tax
|
920.10 | 5.47 | -- | -- | -90.60 |
|
Profit after Tax (Net Income)
|
1,455.70 | 438.44 | -- | -- | -151.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
1,455.70 | -- | -- | -- | -- |
Liabilities ($ Mln)
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
4,009.40 | 3,428.91 | -- | -- | 460.50 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
-- | 4,077.82 | -- | -- | 2,427.70 |
|
Current Liabilities
|
8,749.30 | 493.41 | -- | -- | 835.00 |
|
Total Liabilities
|
16,962.80 | 8,000.14 | -- | -- | 3,901.70 |
Assets ($ Mln)
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
-- | 7,378.66 | -- | -- | 3,207.70 |
|
Current Assets
|
0.00 | 621.48 | -- | -- | 694.00 |
|
Total Assets
|
-- | 8,000.14 | -- | -- | 3,901.70 |
|
Total Debt*
|
-- | 940.00 | -- | -- | 2,359.10 |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,282.40 | 518.71 | -- | -- | 131.50 |
|
Cash Flow from Investing Activities
|
-- | -2,130.36 | -- | -- | 23.60 |
|
Cash from Financing Activities
|
-- | 1,376.77 | -- | -- | -227.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
36.41 | 11.89 | -- | -- | -12.01 |
|
ROE (%)
|
36.41 | 14.10 | -- | -- | 12.60 |
|
ROA (%)
|
8.55 | 6.29 | -- | -- | -6.36 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
2.08 | 27.02 | -- | -- | -5.30 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.06 | 1.10 | -- | -- | 0.08 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
1.99 | 483.63 | -- | -- | -996.35 |
|
EPS Growth (%)
|
-- | 4.17 | -- | -- | -7.13 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -- |
|
Price / Book Value
|
-- | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | -- | -- | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 0.27 | -- | -- | 5.12 |
|
Short term debt to equity ratio
|
-- | -- | -- | -- | 0.62 |
|
Current Ratio
|
0.00 | 1.26 | -- | -- | 0.83 |
|
Quick Ratio
|
-0.10 | -- | -- | -- | 0.71 |
|
Interest Coverage
|
-- | 2.71 | -- | -- | -2.77 |
Operating Efficiency Ratios
| MEDCO HEALTH SOLUTIONS INC (MHS) | Lineage, Inc. (LINE) | Viamet Pharmaceuticals Corp (VMET) | MAKO Surgical Corp (MAKO) | Republic Airways Holdings Inc (RJET) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 17.54 | -- | -- | 3.11 |
|
Asset Turnover
|
4.11 | 0.23 | -- | -- | 1.20 |
|
Receivable days
|
-- | 52.81 | -- | -- | 10.39 |
|
Inventory Days
|
5.34 | -- | -- | -- | 43.69 |
|
Payable days
|
19.19 | -- | -- | -- | 19.51 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | 34.57 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
